EUVIMEDEUVIMED entdecken
Crossref

Advances in GVHD Prophylaxis and the Clinical Significance of HLA Mismatch in Related Donor Hematopoietic Stem Cell Transplantation

Junya Kanda

Major Histocompatibility Complex · 2026 · 33 (1) · 11-18

DOI: 10.12667/mhc.33.11 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Major Histocompatibility Complex, 2026. Verfasst von Junya Kanda. Die Arbeit nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Related donor hematopoietic stem cell transplantation (HSCT) remains an important donor source due to its high availability and rapid accessibility. Historically, the degree of HLA matching has been a key determinant of transplantation outcomes. However, the development of graft-versus-host disease (GVHD) prophylaxis strategies, particularly post-transplant cyclophosphamide (PTCy) and anti-thymocyte globulin (ATG), has significantly improved the safety of HLA-mismatched related donor transplantation. Recent studies have demonstrated that the impact of donor characteristics varies depending on the GVHD prophylaxis strategy, making donor selection based solely on HLA matching insufficient. In addition, advances in immunological understanding, including mechanisms of immune evasion such as HLA loss and epitope-based analyses such as PIRCHE, have provided new insights into donor selection. This review summarizes recent advances in GVHD prophylaxis in related donor HSCT, discusses the clinical significance of HLA mismatch, and highlights emerging strategies for precision donor selection based on immunological compatibility.

Zitieren

APA

Kanda, J. (2026). Advances in GVHD Prophylaxis and the Clinical Significance of HLA Mismatch in Related Donor Hematopoietic Stem Cell Transplantation. Major Histocompatibility Complex, 33(1), 11-18. https://doi.org/10.12667/mhc.33.11

Vancouver

Kanda J. Advances in GVHD Prophylaxis and the Clinical Significance of HLA Mismatch in Related Donor Hematopoietic Stem Cell Transplantation. Major Histocompatibility Complex. 2026;33(1):11-18. doi:10.12667/mhc.33.11

BibTeX
@article{Kanda2026,
  author = {Kanda, Junya},
  title = {Advances in GVHD Prophylaxis and the Clinical Significance of HLA Mismatch in Related Donor Hematopoietic Stem Cell Transplantation},
  journal = {Major Histocompatibility Complex},
  year = {2026},
  volume = {33},
  number = {1},
  pages = {11--18},
  doi = {10.12667/mhc.33.11}
}
Kostenlos starten →